One sentence in the clinical practice guideline published in the May 1, 2020, issue of the Journal (1) contains errors. On page e62, the second sentence of the second paragraph in the committee discussion of Question 2 should read: “In this study, patients with COPD and no history of exacerbations had a 17% [not 39%] increased relative risk of pneumonia and a 52% reduced relative risk of exacerbations (31).”
For the convenience of our readers, the Journal is replacing the online version of the article with a corrected version. These corrections do not change the conclusions or recommendations contained in the guideline.
Reference
- 1. Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd CM, Criner GJ, Donaldson GC, Dreher M, Fan VS, Gershon AS, Han MK, Krishnan JA, Martinez FJ, Meek PM, Morgan M, Polkey MI, Puhan MA, Sadatsafavi M, Sin DD, Washko GR, Wedzicha JA, Aaron SD. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201:e56–e69. doi: 10.1164/rccm.202003-0625ST. [DOI] [PMC free article] [PubMed] [Google Scholar]